CONCLUSION: The ASTride intervention showed efficacy in improving executive functions, hope, and self-efficacy, while reducing anxiety in children with ADHD, supporting its potential as a comprehensive therapeutic approach. Trial registration The research is registered at Clinical Trials.gov, identifier number NCT05869253, first registration at 22/5/2023.
